TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9048274

Group type: EXPERIMENTAL
Intervention: Ophthalmic timolol (50 microL of 0.5%)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 8312212

Group type: EXPERIMENTAL
Intervention: Single insertion of vaginal tablets of prostaglandin E2 (PGE2) containing 3mg of dinoprostin
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Single insertion of vaginal tablets of prostaglandin E2 (PGE2)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (10 singleton pregnant women)
Number of subjects: 20
Study: 3518770

Group type: EXPERIMENTAL
Intervention: Frusemide 10 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Frusemide 20 mg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Bumetanide 250 micrograms
Number of subjects: 10

Group type: COMPARATOR
Intervention: Bumetanide 500 micrograms
Number of subjects: 10
Study: 30853549

Group type: EXPERIMENTAL
Intervention: Fixed N2O/O2 mixture
Number of subjects: 114

Group type: COMPARATOR
Intervention: O2 (placebo)
Number of subjects: 114
Study: 30577815

Group type: EXPERIMENTAL
Intervention: Cd-stressed leaves and roots of ramie
Number of subjects: 0
Study: 27022224

Group type: EXPERIMENTAL
Intervention: Daclatasvir plus peginterferon alfa/ribavirin (pegIFN/RBV)
Number of subjects: 602

Group type: COMPARATOR
Intervention: Telaprevir plus peginterferon alfa/ribavirin (pegIFN/RBV)
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: Daclatasvir plus pegIFN/RBV
Number of subjects: 602
Study: 24529502

Group type: EXPERIMENTAL
Intervention: Clopidogrel therapy (75mg/day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control
Number of subjects: 40
Study: 22023551

Group type: EXPERIMENTAL
Intervention: Thalidomide 100 mg/day
Number of subjects: 400

Group type: COMPARATOR
Intervention: Thalidomide 400 mg/day
Number of subjects: 400
Study: 19682274

Group type: EXPERIMENTAL
Intervention: 8% lidocaine pump spray (XPS)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Saline placebo pump spray (PPS)
Number of subjects: 124
Study: 17227903

Group type: EXPERIMENTAL
Intervention: Increased cytotoxic dose intensity through conventional means (support of hematopoietic growth factors, shortening treatment intervals)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Megadose chemotherapy with the support of autologous bone marrow transplantation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Supportive care improvements (availability of hematopoietic growth factors and peripheral blood progenitor cells)
Number of subjects: 0
Study: 15096921

Group type: COMPARATOR
Intervention: Botox
Number of subjects: 65

Group type: COMPARATOR
Intervention: Zyderm II collagen
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Combination therapy (Botox + Zyderm II collagen)
Number of subjects: 65
Study: 12235445

Group type: EXPERIMENTAL
Intervention: Peppermint oil (600 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Grapefruit juice (300 mL)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ascorbyl palmitate (500 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Water
Number of subjects: 12
Study: 9832592

Group type: EXPERIMENTAL
Intervention: SunSafe intervention promoting sun protection behavior through schools, day care centers, primary care practices, and recreation areas.
Number of subjects: 1930

Group type: COMPARATOR
Intervention: Control towns (paired with intervention towns).
Number of subjects: 1930
Study: 7989386

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin (40 mg of enoxaparin the evening before the operation and once a day subsequently)
Number of subjects: 185

Group type: COMPARATOR
Intervention: Unfractionated heparin (5000 international units the evening before the operation and three times a day thereafter)
Number of subjects: 185
Study: 2648897

Group type: EXPERIMENTAL
Intervention: Oral transmucosal fentanyl citrate (OTFC) 15‐20 micrograms/kg
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Oral solution (meperidine 1.5 mg/kg, diazepam 0.2 mg/kg, atropine 0.02 mg/kg) 0.25 ml/kg
Number of subjects: 59

Group type: COMPARATOR
Intervention: No premedication
Number of subjects: 59
Study: 31856460

Group type: EXPERIMENTAL
Intervention: Tarsorrhaphy (Group A)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Amniotic membrane transplantation (Group B)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 60
Study: 31685472

Group type: EXPERIMENTAL
Intervention: CRS3123 200 mg
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: CRS3123 400 mg
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: CRS3123 600 mg
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: CRS3123 (all doses)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: CRS3123 200 mg and 400 mg
Number of subjects: 30
Study: 29286940

Group type: EXPERIMENTAL
Intervention: CPAP plus SLI P20D20 (20 cm H2O for 20 seconds)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: CPAP plus SLI P20D10 (20 cm H2O for 10 seconds)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: CPAP plus SLI P15D20 (15 cm H2O for 20 seconds)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: CPAP plus SLI P15D10 (15 cm H2O for 10 seconds)
Number of subjects: 100

Group type: COMPARATOR
Intervention: CPAP (5 cm H2O)
Number of subjects: 100
Study: 26345100

Group type: EXPERIMENTAL
Intervention: CAD/CAM lithium disilicate veneering ceramic (CAD-on)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Layered zirconia veneering ceramic
Number of subjects: 60
Study: 23500251

Group type: EXPERIMENTAL
Intervention: 60 mg prasugrel loading dose
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 180 mg ticagrelor loading dose
Number of subjects: 50
Study: 22338130

Group type: EXPERIMENTAL
Intervention: Domestic sevoflurane
Number of subjects: 80

Group type: COMPARATOR
Intervention: Imported sevoflurane
Number of subjects: 80
Study: 19018814

Group type: EXPERIMENTAL
Intervention: Imiquimod 5% cream applied nightly for 6 weeks with occlusion
Number of subjects: 12

Group type: COMPARATOR
Intervention: Vehicle control (not specified in detail)
Number of subjects: 12
Study: 17298349

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate hydrofluoroalkane (FP-HFA) inhaled through the nose using a large volume spacer attached to a face mask
Number of subjects: 60

Group type: COMPARATOR
Intervention: Nasal spray of isotonic saline plus oral inhalation of FP-HFA through a mouthpiece attached to the same spacer
Number of subjects: 60
Study: 15532807

Group type: EXPERIMENTAL
Intervention: Omentoplasty (OP)
Number of subjects: 126

Group type: COMPARATOR
Intervention: No Omentoplasty (NO)
Number of subjects: 126
Study: 15229463

Group type: COMPARATOR
Intervention: 5-fluorouracil (5FU) alone in standard de Gramont regimen (400 mg/m(2) bolus plus 600 mg/m(2) infusion)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: 5-fluorouracil (5FU) plus oxaliplatin (85 mg/m(2)) in standard de Gramont regimen
Number of subjects: 31

Group type: COMPARATOR
Intervention: 5-fluorouracil (5FU) alone in modified de Gramont regimen (400 mg/m(2) bolus plus 2400 mg/m(2) infusion)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: 5-fluorouracil (5FU) plus oxaliplatin (85 mg/m(2)) in modified de Gramont regimen
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Coadministration of oxaliplatin as a covariate in NONMEM analysis
Number of subjects: 31
Study: 11069821

Group type: EXPERIMENTAL
Intervention: Standardized single-breath method (ST)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Modified single-breath, flow-driven method (FD)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: ENO levels measured with ST method
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: ENO levels measured with FD technique
Number of subjects: 115

Group type: COMPARATOR
Intervention: Comparison of ENO levels between ST and FD methods
Number of subjects: 115

Group type: COMPARATOR
Intervention: Comparison of ENO values in steroid-naive vs steroid-treated asthmatic children
Number of subjects: 115
Study: 9244913

Group type: EXPERIMENTAL
Intervention: Visual score
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Expiratory spiral density mask -850 HU
Number of subjects: 25

Group type: COMPARATOR
Intervention: Visual score and expiratory density mask -850 HU
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Residual lung volume measured with expiratory spiral CT
Number of subjects: 25
Study: 8474806

Group type: EXPERIMENTAL
Intervention: Family therapy
Number of subjects: 44

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 44
Study: 3751735

Group type: EXPERIMENTAL
Intervention: Pentazocine (40 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pentazocine (80 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tripelennamine (50 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tripelennamine (100 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pentazocine and tripelennamine combination
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 28656811

Group type: EXPERIMENTAL
Intervention: Intervention 1
Number of subjects: 617

Group type: EXPERIMENTAL
Intervention: Intervention 2
Number of subjects: 617

Group type: COMPARATOR
Intervention: Nonsense Control
Number of subjects: 617

Group type: COMPARATOR
Intervention: Distraction Control
Number of subjects: 617

Group type: EXPERIMENTAL
Intervention: Combined Experimental Groups
Number of subjects: 617
Study: 27208596

Group type: EXPERIMENTAL
Intervention: Picture‐picture evaluative conditioning (EC) procedure, pairing soda images with disgust images and water images with pleasant images.
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control condition (no pairing of images).
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Picture‐picture evaluative conditioning (EC) procedure.
Number of subjects: 84
Study: 23723326

Group type: EXPERIMENTAL
Intervention: High-sensitive cardiac troponin T (hs-cTnT)
Number of subjects: 4197

Group type: EXPERIMENTAL
Intervention: N-terminal pro-B-type natriuretic peptide (NT-pro-BNP) >400 ng/l
Number of subjects: 4197
Study: 22950600

Group type: EXPERIMENTAL
Intervention: Zinc supplementation (100 mg/day for 2 months)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 60
Study: 19465537

Group type: EXPERIMENTAL
Intervention: Moderate-dose MPH (0.6 mg/kg)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Low-dose MPH (0.3 mg/kg)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 106
Study: 18421273

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle modification
Number of subjects: 2921

Group type: EXPERIMENTAL
Intervention: Metformin treatment
Number of subjects: 2921

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2921
Study: 16139336

Group type: EXPERIMENTAL
Intervention: UFH+E
Number of subjects: 60

Group type: COMPARATOR
Intervention: bivalirudin
Number of subjects: 60
Study: 12637462

Group type: EXPERIMENTAL
Intervention: 5'‐DFUR plus CPM
Number of subjects: 1131

Group type: COMPARATOR
Intervention: 5'‐DFUR alone
Number of subjects: 1131
Study: 10471602

Group type: EXPERIMENTAL
Intervention: Inhaled olprinone
Number of subjects: 9

Group type: COMPARATOR
Intervention: Salbutamol
Number of subjects: 9

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 9
Study: 8918172

Group type: EXPERIMENTAL
Intervention: Peer led intervention group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adult led intervention group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonequivalent comparison group
Number of subjects: 0
Study: 1984763

Group type: EXPERIMENTAL
Intervention: Valproate
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 6416401

Group type: EXPERIMENTAL
Intervention: Anatomical injection after diagnosis by selective tissue tension technique
Number of subjects: 77

Group type: COMPARATOR
Intervention: Tender or trigger point localisation injection
Number of subjects: 77
Study: 30715132

Group type: EXPERIMENTAL
Intervention: Progressive subsymptom threshold aerobic exercise
Number of subjects: 103

Group type: COMPARATOR
Intervention: Progressive placebo‐like stretching program
Number of subjects: 103
Study: 28498655

Group type: EXPERIMENTAL
Intervention: Benzimidazole DGAT1 inhibitor 9
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study: 25828621

Group type: EXPERIMENTAL
Intervention: 12 mg/day TT and 103 mg/day PMF
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: 27 mg/day TT and 32 mg/day PMF
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: 12 mg/day TT and 103 mg/day PMF, 27 mg/day TT and 32 mg/day PMF, and Placebo
Number of subjects: 240
Study: 23950599

Group type: EXPERIMENTAL
Intervention: ALAnerv® (2 pills/day for two weeks)
Number of subjects: 28
Study: 20624784

Group type: EXPERIMENTAL
Intervention: Chemotherapy plus bevacizumab
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Chemotherapy plus everolimus
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Chemotherapy plus lapatinib
Number of subjects: 270

Group type: COMPARATOR
Intervention: Chemotherapy alone or plus trastuzumab
Number of subjects: 270
Study: 19319017

Group type: EXPERIMENTAL
Intervention: Green banana (GB) diet (250 g/L) with rice-based diet (54 kcal/dL) for 5 days
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control group (rice-based diet without GB) for 5 days
Number of subjects: 73
Study: 18038549

Group type: EXPERIMENTAL
Intervention: Superlymph (immunotropic drug with direct antimicrobial action)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Superlymph (monotherapy for CABP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable (comparison with healthy subjects)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Not applicable (during treatment)
Number of subjects: 0
Study: 15507066

Group type: EXPERIMENTAL
Intervention: PRP vaccine (Group 1, n=39)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: PRP-OMP conjugate vaccine (Group 2, n=44)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: PRP-D conjugate vaccine (Group 3, n=42)
Number of subjects: 125
Study: 11982666

Group type: EXPERIMENTAL
Intervention: Weighted stair climbing exercise (SCE)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Standardized walking program (WALK)
Number of subjects: 45
Study: 9718095

Group type: EXPERIMENTAL
Intervention: Manual acupuncture
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Acupuncture with low-frequency electrical stimulation (2 Hz)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Electro-acupuncture
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Acupuncture stimulation
Number of subjects: 8
Study: 7715645

Group type: EXPERIMENTAL
Intervention: Comprehensive geriatric assessment (consultation)
Number of subjects: 2353

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 2353
Study: 2744176

Group type: EXPERIMENTAL
Intervention: Fresh semen
Number of subjects: 155

Group type: COMPARATOR
Intervention: Glycerol-preserved semen
Number of subjects: 155

Group type: COMPARATOR
Intervention: TEST-yolk-preserved semen
Number of subjects: 155
Study: 414083

Group type: EXPERIMENTAL
Intervention: Levamisole
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 7199997

Group type: EXPERIMENTAL
Intervention: Glucose infusion at a constant rate of 1 mmol/min
Number of subjects: 8

Group type: COMPARATOR
Intervention: Saline infusion (Control)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Glucose infusion
Number of subjects: 8
Study: 30234848

Group type: EXPERIMENTAL
Intervention: OVRT test battery
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 50
Study: 29388344

Group type: EXPERIMENTAL
Intervention: Intensive format of education (2-day period)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-intensive format of education (series of shorter regular workshops)
Number of subjects: 0
Study: 26851872

Group type: EXPERIMENTAL
Intervention: Alteplase (1 mg/mL)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Urokinase (5000 IU/mL)
Number of subjects: 100
Study: 24890307

Group type: EXPERIMENTAL
Intervention: Barefoot running
Number of subjects: 36

Group type: COMPARATOR
Intervention: Cushioned running shoes
Number of subjects: 36

Group type: COMPARATOR
Intervention: Minimalistic running shoes
Number of subjects: 36
Study: 22823855

Group type: EXPERIMENTAL
Intervention: 21st birthday in-person BASICS
Number of subjects: 599

Group type: EXPERIMENTAL
Intervention: 21st birthday web BASICS
Number of subjects: 599

Group type: EXPERIMENTAL
Intervention: 21st birthday in-person BASICS plus friend intervention
Number of subjects: 599

Group type: EXPERIMENTAL
Intervention: 21st birthday web BASICS plus friend intervention
Number of subjects: 599

Group type: EXPERIMENTAL
Intervention: BASICS
Number of subjects: 599

Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 599
Study: 20004617

Group type: EXPERIMENTAL
Intervention: Ipilimumab 10 mg/kg
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Ipilimumab 3 mg/kg
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Ipilimumab 0.3 mg/kg
Number of subjects: 217
Study: 18273431

Group type: EXPERIMENTAL
Intervention: Cognitive-behaviour therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 12775400

Group type: EXPERIMENTAL
Intervention: Camberwell Assessment of Need for the Elderly (CANE) feedback
Number of subjects: 112

Group type: COMPARATOR
Intervention: Routine practice (control group)
Number of subjects: 112
Study: 10667641

Group type: EXPERIMENTAL
Intervention: Micronized purified flavonoid fraction (MPFF), 1,000 mg/day
Number of subjects: 10000
Study: 9330022

Group type: EXPERIMENTAL
Intervention: Citalopram 20 or 30 mg/day
Number of subjects: 475

Group type: EXPERIMENTAL
Intervention: Citalopram 40 or 60 mg/day
Number of subjects: 475

Group type: EXPERIMENTAL
Intervention: Clomipramine 60 or 90 mg/day
Number of subjects: 475

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 475
Study: 8418781

Group type: EXPERIMENTAL
Intervention: 2 days of antibiotic therapy for low-risk group (n=144)
Number of subjects: 170

Group type: COMPARATOR
Intervention: 5 days of antibiotic therapy for mid to high-risk group
Number of subjects: 170

Group type: COMPARATOR
Intervention: 5 days of antibiotic therapy (historic control subjects)
Number of subjects: 170
Study: 3091975

Group type: EXPERIMENTAL
Intervention: Sodium valproate 600 mg per os
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 28612911

Group type: EXPERIMENTAL
Intervention: Aspirin, clopidogrel, and tirofiban (Group B)
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: Aspirin, ticagrelor, and tirofiban (Group C)
Number of subjects: 258

Group type: COMPARATOR
Intervention: Aspirin and clopidogrel (Control Group A)
Number of subjects: 258
Study: 25411159

Group type: EXPERIMENTAL
Intervention: Biolimus‐A9‐eluting biodegradable-polymer drug‐eluting stents (BP‐DES)
Number of subjects: 2291

Group type: EXPERIMENTAL
Intervention: Second‐generation everolimus‐eluting durable‐polymer drug‐eluting stents (DP‐DES)
Number of subjects: 2291

Group type: COMPARATOR
Intervention: Thin‐strut silicon‐carbide‐coated bare-metal stents (BMS)
Number of subjects: 2291

Group type: EXPERIMENTAL
Intervention: All stent groups
Number of subjects: 2291
Study: 23647756

Group type: EXPERIMENTAL
Intervention: Rectangular fields (n=79)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Conformal fields (n=85)
Number of subjects: 164
Study: 21092936

Group type: EXPERIMENTAL
Intervention: Individual positive memory imagery
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Individual soothing imagery
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Distracting task
Number of subjects: 17

Group type: COMPARATOR
Intervention: Neutral comparison condition
Number of subjects: 17
Study: 19230897

Group type: EXPERIMENTAL
Intervention: Limited-channel aEEG monitoring (visible group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Limited-channel aEEG monitoring (blinded group)
Number of subjects: 0
Study: 17279845

Group type: EXPERIMENTAL
Intervention: Need for closure (NFC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Consensus motives
Number of subjects: 0
Study: 15182277

Group type: EXPERIMENTAL
Intervention: 400 mg/day theophylline for 4 weeks
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 11160544

Group type: EXPERIMENTAL
Intervention: Exclusive breastfeeding (EBF) until 6 months
Number of subjects: 260

Group type: COMPARATOR
Intervention: Solid foods (SF) introduced between 4 and 6 months
Number of subjects: 260
Study: 9783616

Group type: EXPERIMENTAL
Intervention: Kapandji pinning
Number of subjects: 98

Group type: COMPARATOR
Intervention: Closed reduction and plaster application
Number of subjects: 98
Study: 7614398

Group type: EXPERIMENTAL
Intervention: Immediate and short‐term postoperative instillation of peplomycin sulfate
Number of subjects: 46

Group type: COMPARATOR
Intervention: Simple irrigation (control)
Number of subjects: 46
Study: 3580317

Group type: EXPERIMENTAL
Intervention: Local infiltration with saline before the episiotomy repair
Number of subjects: 0

Group type: COMPARATOR
Intervention: Epidural analgesia (control group)
Number of subjects: 0
Study: 31025828

Group type: EXPERIMENTAL
Intervention: Life story work (LSW) intervention, participants worked with a volunteer to prepare a life storybook.
Number of subjects: 244

Group type: COMPARATOR
Intervention: Control group participated in a social program.
Number of subjects: 244
Study: 26642740

Group type: EXPERIMENTAL
Intervention: Grassland-survival scenario (Studies 1-3)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rating words for pleasantness (Study 2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Explicit learning (Study 3)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-survival scenario of moving to a foreign land (Study 1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-survival scenario of moving to a foreign land (Study 2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Planning a trip as a tour guide (Study 3)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control study (Study 4)
Number of subjects: 0
Study: 25876611

Group type: EXPERIMENTAL
Intervention: Ambrisentan 5 mg daily for one month and then 10 mg daily for two months
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 24064347

Group type: EXPERIMENTAL
Intervention: salbutamol
Number of subjects: 38

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 38